Related Experiment Video
Updated: Jul 20, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Thrombin generation in normal plasma enriched with purified coagulation factors
Thrombosis Research
|February 1, 1983
Summary
The extrinsic coagulation pathway drives complete prothrombin to thrombin conversion, unlike the intrinsic pathway. Adding more prothrombin increases thrombin generation proportionally but not efficiency.
Area of Science:
- Biochemistry
- Hematology
- Physiology
Background:
- Prothrombin (clotting factor II) is a key enzyme precursor in the coagulation cascade.
- Coagulation occurs via intrinsic and extrinsic pathways, both leading to thrombin generation.
- The efficiency of prothrombin conversion to thrombin differs between these pathways.
Purpose of the Study:
- To investigate the quantitative differences in prothrombin conversion to thrombin between the intrinsic and extrinsic coagulation pathways.
- To elucidate the role of factor Xa in prothrombin activation under different pathway conditions.
Main Methods:
- Thrombin elution assay to quantify generated thrombin.
- Thrombin generation test to assess thrombin activity over time.
- Activated partial thromboplastin time (APTT) assay to measure intrinsic pathway function.
Main Results:
- Intrinsic pathway converts only 11% of prothrombin to thrombin in normal plasma.
- Extrinsic pathway achieves complete prothrombin conversion.
- Prothrombin addition proportionally increased thrombin generation but not conversion efficiency.
- Factor Xa generates more thrombin in the presence of tissue factor (extrinsic) than with activated partial thromboplastin (intrinsic).
Conclusions:
- The extrinsic pathway is significantly more efficient in prothrombin activation than the intrinsic pathway.
- Differences in factor X activation and factor Xa activity contribute to pathway-specific prothrombin activation levels.
Related Concept Videos
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...